Anthony Mangum July 17, 2024 FDA grants approval to DiscGenics for Phase III trial of cell therapy Anthony Mangum July 17, 2024 Clinical Trials Arena
Anthony Mangum July 9, 2024 Discgenics’ cell therapy on phase III track for disc degeneration Anthony Mangum July 9, 2024 BioWorld
Anthony Mangum March 25, 2024 Noninvasive Injectables for Chronic Low Back Pain Anthony Mangum March 25, 2024 IEEE Pulse
Daniel Ashton September 5, 2023 A Revolutionary Approach to Treating Degenerative Disc Disease: Merge Medical Podcast with DiscGenics Daniel Ashton September 5, 2023 Merge Medical Podcast
caleb kingston July 17, 2023 A New Era in Spinal Care: FORCE Family Office Fireside Chat with DiscGenics and Piper Sandler caleb kingston July 17, 2023 FORCE Family Office Webinar
caleb kingston May 3, 2023 Force Family Office Fireside Chat: Expert Panel Discusses DiscGenics’ Potential Cure for Degenerative Disc Disease caleb kingston May 3, 2023 FORCE Family Office Webinar
Anthony Mangum April 13, 2023 Achieving Regeneration in Lumbar Degenerative Disc Disease Anthony Mangum April 13, 2023 CGTLive
Anthony Mangum February 27, 2023 High-dose allogeneic disc progenitor cells may improve low back pain Anthony Mangum February 27, 2023 Orthopedics Today
Anthony Mangum February 7, 2023 DiscGenics receives FDA RMAT designation for IDCT for degenerative disc disease Anthony Mangum February 7, 2023 Spinal News International
Anthony Mangum January 26, 2023 Discogenic Progenitor Cell Therapy Shows Improvements in Lumbar Degenerative Disc Disease, Recognized by FDA Anthony Mangum January 26, 2023 CGTLive
Anthony Mangum February 28, 2022 DiscGenics reports positive Phase I/II data from degenerative disc disease trial Anthony Mangum February 28, 2022 Clinical Trials Arena
Anthony Mangum February 28, 2022 DiscGenics Touts Positive Clinical Data for DDD Cell Therapy Anthony Mangum February 28, 2022 Orthopedic Design & Technology
Anthony Mangum February 9, 2021 DiscGenics completes construction on Salt Lake City HQ — 7 things to know Anthony Mangum February 9, 2021 Becker’s Spine Review
Anthony Mangum October 22, 2020 DiscGenics Raises $50 Million For its Novel Back Pain Treatment Anthony Mangum October 22, 2020 TechBuzz News
Anthony Mangum September 18, 2020 Living Progenitor Cells Edge Closer to "Cure-All" Status Anthony Mangum September 18, 2020 Orthopedics This Week
Anthony Mangum September 9, 2020 Former Medtronic Spine and Biologics exec appointed DiscGenics CFO Anthony Mangum September 9, 2020 Becker’s Spine Review
Anthony Mangum August 27, 2020 DiscGenics Raises $50M in Series C Funding Anthony Mangum August 27, 2020 FinSMEs
Anthony Mangum June 22, 2020 Alleviating chronic back pain: an interview with Isaac Erickson Anthony Mangum June 22, 2020 RegMedNet
Anthony Mangum March 4, 2020 DiscGenics Announces Completion of Enrollment in U.S. Phase 1/2 Clinical Trial of Discogenic Cell Therapy for Degenerative Disc Disease Anthony Mangum March 4, 2020 OrthoSpineNews
Anthony Mangum February 26, 2020 Why Cell-Based Therapies Could Be an Alternative to Opioids Anthony Mangum February 26, 2020 Future of Personal Health
